Introduction
Calcineurin inhibitors (CNIs) are notorious for inducing acute and chronic nephrotoxicity [1, 2] . CNI-induced modifications of kidney graft function are observed during early post-transplantation periods, with changes in preglomerular afferent arteriolar vasoconstriction resulting in pathognomonic histomorphological lesions [2, 3] . These effects are generally reversible upon reduction of CNI dosage. Continuous administration is associated with chronic vascular and tubulointerstitial lesions; further, vascular injury and arteriolar hyalinosis lead to ischaemic glomerular sclerosis and tubular atrophy. Chronic ischaemia resulting from vascular obliteration causes stripped interstitial fibrosis, a typical and irreversible effect present in ∼25% of patients during the first 6 months post-transplantation [2, 4, 5] . Biochemical events associated with the nephrotoxic actions of CNIs include increased endothelin-1 and tumour necrosis factor beta (TGFβ) production, alterations of the prostaglandin/thromboxane system, increased renin/angiotensin system activation and generation of oxidative stress [1] . Although mainly described for cyclosporine A, these events are also observed with tacrolimus. Avoidance or limited use of a CNI following renal transplantation is therefore considered desirable [6] .
Uniform criteria for predicting renal impairment during the early post-transplantation period have not been established. However, duplex Doppler ultrasonography, originally introduced to screen for non-vascular diseases of native kidneys, has been found effective for identifying various causes of graft insufficiency at early post-transplantation times [7] . Serial determinations of resistive (RI) and pulsatility (PI) indices with this technique allow estimation of the degree of interstitial oedema and intrarenal vascular impedance. After obtaining spectra from segmental arteries at five representative locations, RI and PI are calculated as follows [8] : RI = (peak systolic frequency shift − minimum diastolic frequency shift) / peak systolic frequency shift PI = (peak systolic frequency shift − minimum diastolic frequency shift) / mean frequency shift
The average RI and PI values are then computed to yield overall RI and PI values. Consideration of maximum RI and PI values is proposed to improve diagnostic efficacy as early as 5 days post-transplantation [9] . Evaluations depend mainly on arterial blood flow during diastole [10, 11] ; flow may be disturbed due to increased intrarenal resistance or may be absent in conditions such as acute tubular necrosis. Using duplex Doppler ultrasonography, the acute narrowing of intrarenal vessels in response to CNI treatments has been shown to be rapidly reversible [12] . Changes in RI and PI have been found to correlate with changes in renal vascular resistance, renal blood velocity and wall sheer stress before and 1 month after percutaneous transluminal angioplasty and stenting in subjects with renal artery stenosis [13] . This approach has also been used to demonstrate that ischaemic injury occurring prior to organ harvesting plays a dominant role in determining intrarenal resistance in the early posttransplantation period [11] . Although PI and RI elevations may be attributable to various causes, including age of donor and recipient, ureteral obstruction, extrarenal graft compression and vasomotor changes induced by pharmacologic agents, RI values of 0.80 or higher are closely associated with allograft failure or recipient death [10, 14] . RI and PI measurements are therefore expected to reveal the presence of allograft nephropathy during the early post-transplantation period without a need for biopsy.
The immunosuppressive effects of CNIs are mediated by inhibition of T-cell activation through suppression of the calcineurin-catalysed dephosphorylation required for nuclear factor of activated T cell (NFAT)-dependent induction of cytokine genes. Whether CNI-induced nephrotoxicity is secondary to suppression of the calcineurin-NFAT pathway remains to be established [2] . Nonetheless, sirolimus (rapamycin, SRL), an immunosuppressant with a different mechanism of action, is not currently thought to impair the function of an uninjured kidney [15] . SRL is widely used for its ability to prolong short-and long-term graft survival and for its efficacy when combined with other antiproliferative drugs [16] . The objective of this study was to examine the influences of recipient factors and of CNI-free, as compared to CNI-based, immunosuppressant regimens on intrarenal vascular resistance parameters in renal transplant patients through use of duplex Doppler ultrasonography. To our knowledge, this study is the first to evaluate intrarenal vascular impedance in kidney transplant recipients with respect to treatment without, as compared to with, a CNI. It was hypothesized that use of SRL would result in significantly lower RI and PI values.
Subjects and methods
Between January 2007 and December 2007, consecutive patients who had sustained a renal transplant for at least for 1 year and who displayed relatively acceptable renal function were followed at our patient department and considered for inclusion in this case-control study. Exclusion criteria were graft infection, acute pyelonephritis, acute urinary infection and graft rejection. The procedures followed were in accordance with the ethical standards of our institutional committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 2000.
A total of 49 kidney transplant recipients were included. Subjects received an immunosuppressant regimen either containing a CNI (CNI group, cyclosporine A or tacrolimus, n = 31) or lacking a CNI (SRL group, n = 18) for a treatment period of more than six months. Subjects were not randomly assigned to groups but were treated according to the preferences of their attending physicians. SRL was prescribed either as the initial immunosuppressant or for rescue or substitution purposes. The period from renal transplantation to performance of graft ultrasonography in the CNI group was between 13 and 90 months and in the SRL group was between 18 and 85 months. Target cyclosporine A trough concentrations were 150-180 ng/mL. Target tacrolimus trough concentrations were 8-10 ng/mL, and target SRL trough concentrations were 5-10 ng/mL. Doppler ultrasonography was performed every 3 months post-transplantation. No acute or chronic rejections were observed at the time of examination. The presence of underlying diabetes, hypertension or other systemic diseases was recorded. Body weight, systolic and diastolic blood pressures, degree of proteinuria and white blood cell count were measured regularly and recorded. Blood urea nitrogen (BUN), creatinine, proteinuria, glomerular filtration rate (GFR), blood glucose, cholesterol, triglyceride and uric acid values were also determined routinely and recorded.
All Doppler ultrasonographic measurements were performed by the same operator using an HDI-5000 ultrasound scanner (Advanced Technology Laboratories, Bothell, WA) and a 2-50 MHz convex array broadband transducer. All analyses were performed between 2:00 and 4:00 p.m. Because the RI relative to the CNI dose has been observed to rise in the 1-2-h period following administration of cyclosporine A [17] , sonography was performed on all patients at least 6 h after mediation. Intrarenal Doppler signals were obtained from three to four representative proximal segmental arteries (the first vessels branching off the main renal artery).
After peak systolic (Vmax) and minimal diastolic (Vmin) velocities were determined, the renal segmental arterial RI and the PI were calculated. Findings from three or four measurements were averaged.
Medians with interquartile ranges were calculated for continuous variables, and the Mann-Whitney U-test was used to compare the differences between the CNI and the SRL groups. Numbers and percentages are shown for categorical variables as analysed by the chi-square test; when more than 20% of the cells had expected values in excess of five, the Fisher's exact test was selected. As further confirmation of the factors related to the RI or the PI, univariate linear regression analysis was performed; factors with P-values <0.2 were used to perform multivariate linear regression analysis. Stepwise multivariate linear regression models were then established. A significance level of 0.05 was defined. All statistics were two-sided and implemented by SPSS software (version 15.0, SPSS Inc., Chicago, IL, USA).
Results
Forty-nine subjects, 30 males and 19 females, were analysed. The average age was 50.1 (SD: 10.9; range: 21.4-71.0) years, mean graft age was 56.2 (SD: 34.6, range: 12.0-178.0) months and the mean body mass index (BMI) was 22.9 (SD: 3.2; range: 16.9-31.7) kg/m 2 . The majority of subjects did not have diabetes (83.7%) but hypertension was common (65.3%). Approximately onethird of all subjects utilized a beta-blocker (26.5%) or a calcium channel blocker (30.6%), but only a few subjects received an angiotensin-converting enzyme inhibitor (ACEI; 6.12%), alpha-blocker (8.16%) or diuretic (6.1%) (data not shown).
The characteristics of the subjects in this study are summarized in Table 1 . As compared to subjects in the CNI group, more subjects in SRL group were treated with a calcium channel blocker (55.6% vs. 16.1%; P = 0.0004). Additionally, those in the SRL group exhibited higher cholesterol (229.50 vs. 195.00 mg/dL; P = 0.046) and triglyceride (164.50 vs. 91.00 mg/dL; P = 0.006) values while displaying lower RI (0.63 vs. 0.69; P = 0.002) and PI (1.13 vs. 1.29; P = 0.034) values. However, no differences in patient age, BMI, gender, graft age, proteinuria, GFR or other variables (all P > 0.05) were observed between the two groups.
By univariate linear regression analysis, four factors were found to be related to the RI ( Table 2 ). The RI score was found to rise with increasing age. Furthermore, transplant recipients receiving an alpha-blocker also displayed higher RI values (P < 0.05). RI values were not found to correlate with CNI dosage by univariate analysis (data not shown). By contrast, lower RI values were observed in subjects who used SRL (P = 0.002). When multivariate analysis was performed, RI was also found to increase significantly with age and use of an alphablocker or diuretic and to decrease with use of SRL (all P < 0.05, Table 2 ).
Factors related to the PI are presented in Table 3 . Univariate analysis revealed that the PI increased with advancing age and with an alpha-blocker or diuretic treatment but decreased with use of SRL (all P < 0.05). By multivariate regression analysis, the correlations between PI and increasing age and between PI and use of the antihypertensive agents (alpha-blockers and diuretics) retained their significance (P < 0.001, P = 0.027 and P = 0.012, respectively). However, the negative correlation between PI and use of SRL observed by univariate analysis was not significant by multivariate analysis (P = 0.053).
Discussion
The present study is the first to employ color Doppler ultrasonography to evaluate intrarenal vascular parameters in kidney transplant patients receiving either CNI-free (SRLcontaining) or CNI-based immunosuppressant regimens. As anticipated, recipient factors of advanced age and requirement for diuretics or alpha-blockers were correlated with higher RI and PI values. Surprisingly, however, the CNI-free regimen was found to be only modestly correlated with lower RI values and was not significantly correlated with reduced PI values. These observations cast doubt on the superiority of CNI-free over CNI-containing regimens for reducing intrarenal vascular resistance post-transplantation and also question the specificity of intrarenal As compared to subjects with urinary WBC counts ≤5/HPF. resistance indices for predicting allograft function and/or survival. Although previous studies have not supported a close relationship between RI and PI values and the degree of short-term or long-term allograft function [18] , an association between high RI and PI values and normal kidney function appears to be rare. Cutoff values of RI >0.8 and of PI >1.8 are generally characteristic of both allograft failure and death with a functioning graft [14] but are not pathognomonic. In the present study, as well as in other studies [14, 19, 20] , extrarenal characteristics of kidney recipients such as age and presence of hypertension were found to correlate more strongly with RI and PI values than did use of CNIs or anti-hypertensive agents. RI and PI values are therefore proposed to reflect more accurately the compliance of the central arteries of the recipient rather than allograft properties or vasculature. This appears to be the case for the higher intrarenal blood flow parameters characteristically observed in older recipients, especially those with hypertension [21] . Furthermore, elevations in RI and PI values have been attributed to atherosclerosis-reduced pre-renal aortic compression chamber function, to vascular stiffness, and to increased intima-media thickness secondary to ageing and end-stage renal disease rather than to impaired allograft function per se [22, 23] . Whether catecholamine infusions, diuretics or alpha-blockers were administered to subjects of these studies because of post-transplantation circulatory impairments or ischaemia, as represented by higher RI and PI values, or because of hypotensive episodes and circulatory impairments present prior to transplantation is difficult to ascertain. Regardless, traditional cardiovascular risks are known to be correlated with RI values and account for ∼50% of deaths of patients with functioning grafts [24] .
The implications of the present findings regarding SRLcontaining regimens to allograft function or survival are unclear. However, the significantly lower RI (P = 0.003) and lower but statistically insignificant PI (p = 0.053) associated with use of SRL may be theoretically explained by the ability of this immunosuppressant to attenuate immune-obliterative arterial and arteriolar pathophysiological processes characteristic of CNIs. Whereas CNIs induce constriction of the afferent arteriole proximal to the glomerulus [25] and accumulation of nodular hyaline deposits in the media conducive to obliterative arteriolopathy, SRL has been shown to decrease arterial intimal thickening in cynomolgus monkey recipients of allografts [26] . The observed association of SRL use with a lower RI must nevertheless be interpreted with caution, as the administration of alpha-, betaand calcium channel blockers was not accounted for during the multivariate regression analyses. In this regard, it is of interest that no correlation between use of a CNI in stable kidney patients and higher RI and PI values, irrespective of the use of antihypertensive agents, was observed by other investigators [14, 19, 20] . These findings further serve to highlight the non-specificity of intrarenal resistance indices as determinants of allograft function or survival.
Estimated graft function with SRL-based immunosuppression has been found superior to CNI-based immunosuppression at 1 year post-transplantation [27] . However, it should be noted that, although SRL-based regimens are not associated with vasomotor nephrotoxicity, SRL may not be entirely without renal effects [15] . For example, this inhibitor of the mammalian target of rapamycin has been observed to exacerbate the nephrotoxicity occurring in response to large doses of CNIs in animal model studies and in phase III trials in human renal transplantation. Furthermore, certain findings with animal models and reports of non-randomized experiences at single centres are consistent with the hypothesis that SRL delays recovery from a tubular injury. However, this hypothesis has not been confirmed by randomized, multi-center and larger single-centre studies. A relatively small fraction of subjects treated with SRL de novo may exhibit prolongation of delayed graft function. Finally, SRL-based immunosuppression is associated with an increased frequency of semiquantitative proteinuria [27] .
Certain limitations of the present study are acknowledged. Firstly, protocol biopsies were not performed routinely; renal biopsies were performed only when the possibility of rejection was suspected. Secondly, the conditions of each individual graft were not determined. Because such determinations are extremely difficult and laborious, graft conditions were evaluated in terms of age, BUN, GFR and proteinuria. Thirdly, the findings presented here derive from a relatively small sample number. At the present time, data has been collected from 60 patients; the study is ongoing with expansion of the data base considered a primary long-term objective. With a larger sample number, it should also prove feasible to ascertain whether the CNI inhibitors cyclosporine A and tacrolimus differentially alter intrarenal vascular resistance parameters in kidney transplant recipients.
In conclusion, findings of the present study confirm that recipient factors of advanced age and requirement for diuretic or alpha-blocker therapy correlate with increased RI and PI values in kidney transplant recipients. However, use of an SRL-based regimen was found to be correlated only modestly with lower RI and not with lower PI values. The latter findings do not provide conclusive evidence for the superiority of CNI-free as compared to CNI-based regimens in terms of reducing intrarenal vascular resistance post-transplantation and highlight the non-specificity of intrarenal resistance indices for predicting allograft function or survival.
